Abbott Proclaim 3660 Clinician Manual page 53

Implantable pulse generator
Table of Contents

Advertisement

Table 27. Summary of IPG recharging for all available subjects
IPG Recharging
Week 24
Recharged
Yes
Frequency
Daily
2–3 times a week
Weekly
Every other week
Once a month or less often
Reason
Battery heats up
Charged daily due to time it took
(1.5 hours daily or more than 3
hours if patient waited)
Low battery message
Normal routine
Recommended time frame
Unscheduled between weeks 12 and 24
Recharged
Yes
Frequency
2–3 times a week
Weekly
Once a month or less often
Reason
Normal routine
Recommended time frame
SUNBURST™ Study Results
This section provides results from the SUNBURST™ study.
Primary Effectiveness
The analysis of effectiveness was an intention-to-treat analysis based on the randomization
population of 100 subjects.
Statistical methods were used to impute VAS scores for the following subjects and reasons:
Six (6) subjects increased pain medication in during the 12 weeks following device activation
(2 while using tonic and 4 while using burst) and 15 subjects increased pain medication in
between weeks 12 and 24 (5 while using burst and 10 while using tonic), and their overall
VAS score at the trial baseline was used to impute their overall VAS score for the week-12 or
week-24 visit as appropriate per the protocol.
Four (4) subjects withdrew from the study before week 24, and their overall VAS score was
imputed using the hot deck method, which replaces missing values of a visit for a non-
respondent with observed values during the same visit from a respondent who shares similar
characteristics observed by both cases.
Burst
45/45 (100.00%)
3/45 (6.67%)
13/45 (28.9%)
25/45 (55.6%)
4/45 (8.89%)
0/45 (0.0%)
1/45 (2.22%)
1/45 (2.22%)
1/45 (2.22%)
42/45 (93.3%)
0/45 (0.0%)
11/11 (100.00%)
0/11 (0.0%)
10/11 (90.9%)
1/11 (9.09%)
10/11 (90.9%)
1/11 (9.09%)
49
Tonic
50/51 (98.04%)
2/50 (4.00%)
8/50 (16.0%)
32/50 (64.0%)
7/50 (14.0%)
1/50 (2.00%)
0/50 (0.0%)
0/50 (0.0%)
3/50 (6.00%)
46/50 (92.0%)
1/50 (2.00%)
7/7 (100.00%)
3/7 (42.9%)
4/7 (57.1%)
0/7 (0.0%)
7/7 (100.00%)
0/7 (0.0%)

Hide quick links:

Advertisement

Table of Contents
loading

Table of Contents